[Abstract] All seven retinal cell types that make up the mature retina are generated from a common, multipotent pool of retinal progenitor cells (RPCs) (Wallace, 2011) . One way that RPCs know when sufficient numbers of particular cell-types have been generated is through negative feedback signals, which are emitted by differentiated cells and must reach threshold levels to block additional differentiation of that cell type. A key assay to assess whether negative feedback signals are emitted by differentiated cells is a heterochronic pellet assay in which early stage RPCs are dissociated and labeled with BrdU, then mixed with a 20-fold excess of dissociated differentiated cells. The combined cells are then re-aggregated and cultured as a pellet on a membrane for 7-10 days in vitro. During this time frame, RPCs will differentiate, and the fate of the BrdU + RPCs can be assessed using cell type-specific markers.
the signals reach threshold levels (Belliveau and Cepko, 1999; Reh and Tully, 1986; Waid and McLoon, 1998) . We and other have demonstrated that Shh is an essential negative regulator of a RGC fate (Wang et al., 2005; Zhang and Yang, 2001 ). We also dissected the feedback process for retinal amacrine cells, showing that the transcription factor Zac1 acts in amacrine cells to initiate transforming growth factor b2 (Tgfb2) expression, which negatively regulates RPC proliferation and amacrine cell differentiation (Ma et al., 2007) . Notably, other TGFβ family members have similar feedback functions in the olfactory epithelium (Wu et al., 2003) , pancreas (Harmon et al., 2004) , and skeletal muscle (Tobin and Celeste, 2005) . We also used the heterochronic pellet assay to examine how amacrine cell feedback signals are themselves regulated. We found that Pten is an essential positive regulator of amacrine cell differentiation, and using the pellet assay, we demonstrated that Pten acts in RPCs to control responsiveness to Tgfβ2 signaling (Tachibana et al., 2016) . Understanding how amacrine cells and RPCs interact provides important new insights into how cell number is controlled in the retina. Notably, similar interactions between Pten and Tgfβ signaling may underlie cell number control in other vertebrate organs where Tgfβ signaling is an important determinant of organ size. A. Dissociating E15.5 mouse retina 1. Enucleate the eyes from E15.5 CD1 embryos at room temperature (see Note 1 about mice).
Materials and Reagents
2. Place eyes in Petri dish and add cold 1x DPBS to cover ( Figure 1A ). 6. Add 100 μl of 0.125% trypsin (pre-warmed to 37 °C) to retinas, and incubate in 37 °C water bath for 10 min ( Figure 1D ). Please note that retina will not break apart on its own. Trituration is required to break cell-cell interactions.
7. Add 5 ml of 20% FBS/1x DPBS to stop trypsinization.
8. Homogenize retinal cells completely by pipetting up and down several times (i.e., at least 30 times) using a 5 ml pipet (i.e., triturate; Figure 1E ) until no clusters of cells are observed www.bio-protocol.org/e2117 10. Re-suspend cells in 1 ml of REM (pre-warmed to 37 °C).
11. Add 3 µl of 1 mg/ml BrdU into cell resuspension. Vortex gently and briefly to mix.
12. Incubate cell resuspension for 1 h at 37 °C, 5% CO2 in water jacketed incubator.
B. Dissociating P2 mouse retina 1. Meanwhile, dissect P2 mouse retinas by enucleating the eyes, and removing RPE and lens as described above (see Note 2 and Note 3 about mice).
2. Transfer retinas into 15 ml Corning tube (with 10 ml of 1x DPBS at room temperature), keeping the two retinas from each mouse together in a separate tube as the genotype of each mouse is different. Allow retinas to sink to tube bottoms.
3. Remove as much 1x DPBS as possible, then add 100 µl of 0.125% trypsin, and incubate in 37 °C water bath for 10 min.
4. Stop the reaction by adding 5 ml of 20% FBS/1x DPBS, and triturate the cells by pipetting gently several times with 5 ml pipet and pipette pump.
5. Spin down at 520 x g for 5 min, and remove solution as much as possible.
6. Re-suspend the cells with 1 ml REM (pre-warmed to 37 °C).
C. Preparation of heterochronic cell pellet 1. Remove E15.5 CD1 dissociated cells from the incubator after 1 h incubation in BrdU.
2. Spin down cells at 520 x g for 5 min, remove media as much as possible, then re-suspend in 1 ml REM. Repeat this step twice more to completely remove any trace of BrdU. Re-suspend the cells in 1 ml REM (pre-warmed to 37 °C).
www.bio-protocol.org/e2117 Calculate the concentration of each cell resuspension using hemacytometer (calculation described in Figure 2 ). Make sure that the cells are dissociated completely (i.e., no clumps of cells or doublets). If you see any clumps, we recommend to re-dissociate the cells. 2. Place slides in pre-warmed 2 N hydrochloric acid and incubate at 37 °C for 20 min.
3. Rinse slides in distilled H2O several times to remove as much hydrochloric acid as possible.
4. Wash three times for 5 min in 1x PBS to equilibrate the pH of the slides.
5. Remove slides from 1x PBS and apply paper towel on the edge of the slide to remove excess liquid.
6. Apply 400 μl of blocking solution (10% horse serum/1x PBT) per slide and incubate at room temperature for 1 h. Make sure blocking solution is spread thoroughly to cover the entire surface of the slides.
7.
Remove as much blocking solution as possible, then apply 200 μl of primary antibodies diluted in blocking solution (see Table 1 for dilution) and place Parafilm to cover entire surface of the slides. Incubate at 4 °C overnight.
8. Wash slides three times for 10 min in 1x PBS.
9. Apply 200 μl of secondary antibodies (see Table 1 ) and DAPI diluted in 1x PBT (1:500 and 1:5000 dilution respectively) and place Parafilm on top to cover solution. Incubate at room temperature for 1 h. Avoid incubating under light as fluorescence is light-sensitive.
10. Wash slides three times for 10 min in 1x PBS.
11. Apply Aqua-Poly/Mount and mount with coverslip.
12. Take several images (3 or more) of sections of the retinal cell aggregates with upright fluorescence microscope ( Figure 1I ).
Data analysis
1. For experimental design, to compare two data sets, we perform the pellet assay a minimum of three times. To compare three or more data sets, we perform a minimum of four experiments.
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For each experiment, we use a minimum of three replicates. For each replicate, we analyse 3-10 photomicrographs so as to count a minimum of 500 BrdU + cells.
2. For data analysis, to assess the fate of BrdU-labeled retinal progenitor cells, we analyse a minimum of 3 cryosections from each pellet (Figures 4A and 4B) . We take photomicrographs of each immunostained cryosection, and count the total number of BrdU + cells and the number of BrdU + cells that express a cell type-specific marker. For amacrine cells, as an example, we use
Pax6 as a cell type-specific marker ( Figure 4A ). www.bio-protocol.org/e2117 ). Cell strainers can be used to remove clumps as an alternative for tissues that are difficult to dissociate.
6. When making the aggregate pellets, we highly recommend to make at least five replicates per sample as you may lose pellets during culturing (e.g., If they sink). This will allow you to have at least three replication controls for each experiment, which should provide a good indication of experimental variability.
7. When dislodging the pellet from the bottom of the 15 ml tube, do not apply too much force as it is easy to break apart the pellet. We usually pipet 500 μl of liquid using a P1000 pipetman and slowly dispense liquid on the edge of the pellet. You should see the pellet float in the liquid and then it is easy to pick up. Aliquot 500 μl of horse serum into 15 ml tube and add 4.5 ml 1x PBT Vortex to mix thoroughly 11. Primary antibodies are diluted in blocking solution as described in Table 1 12. Secondary antibodies are diluted 1/500 in PBT. DAPI pre-made commercial solution is added at 1/500. Secondary antibodies are listed in Table 1 . 
